Evidence map›Paper›PMID 28265339›Full record

ReviewOxidative medicine and cellular longevity2017

Oxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy.

Cheng Li, Xiao Miao, Fengsheng Li, Shudong Wang, Quan Liu, Yonggang Wang, Jian Sun

Open access · hybridAbstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed, 1 pooled it
14.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 1 synthesis or guideline pooled it, 179 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Observational
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Cheng LiThe First Hospital of Jilin University, Changchun 130021, China.ORCID 0000-0003-2439-1627
Xiao MiaoThe Second Hospital of Jilin University, Changchun 130041, China.
Fengsheng LiGeneral Hospital of the PLA Rocket Force, Beijing 100088, China.ORCID 0000-0001-5051-9669
Shudong WangThe First Hospital of Jilin University, Changchun 130021, China.ORCID 0000-0003-2017-8968
Quan LiuThe First Hospital of Jilin University, Changchun 130021, China.ORCID 0000-0001-7408-0048
Yonggang WangThe First Hospital of Jilin University, Changchun 130021, China.ORCID 0000-0003-0370-4591
Jian SunThe First Hospital of Jilin University, Changchun 130021, China.ORCID 0000-0002-4257-8674
Jilin University · CNAir Force General Hospital PLA · CNSecond Affiliated Hospital of Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic retinopathy (DR) is one of the most common microvascular complications of diabetes and is the leading cause of blindness in young adults. Oxidative stress has been implicated as a critical cause of DR. Metabolic abnormalities induced by high-glucose levels are involved in the development of DR and appear to be influenced by oxidative stress. The imbalance between reactive oxygen species (ROS) production and the antioxidant defense system activates several oxidative stress-related mechanisms that promote the pathogenesis of DR. The damage caused by oxidative stress persists for a considerable time, even after the blood glucose concentration has returned to a normal level. Animal experiments have proved that the use of antioxidants is a beneficial therapeutic strategy for the treatment of DR, but more data are required from clinical trials. The aims of this review are to highlight the improvements to our understanding of the oxidative stress-related mechanisms underlying the development of DR and provide a summary of the main antioxidant therapy strategies used to treat the disease.

Indexed as

AnimalsAntioxidantsDiabetic RetinopathyHumansOxidative StressAntioxidants

Identifiers

PMID28265339
PMCPMC5317113
OpenAlexW2587073861

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.